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Studies of the Glycine Cleavage Enzyme System in Brain from Infants with Glycine Encephalopathy
Summary Glycine content and enzyme activity o f the glycine cleavage system were compared i n autopsied brain from five infants dying with glycine encephalopathy and four control infants. including t w o with other types o f hyperglycinemia. Glycine content was elevated 2-t o 8-fold and glycine cleavage enzyme activity was undetectable i n the brains o f the glycine encephalopathy patients. Glycine content and enzyme activity \rere normal i n the brains o f the control patients, including one w i t h ketotic hyperglycinemia secondary t o methylmalonic acidemia. Prolonged dialysis failed to restore glycine cleavage enzyme activity i n brain homogenates of glycine encephalopathy patients, and these homogenates failed to inhibit enzyme activity when added to homogenates o f control brain. Radioactive bicarbonate was converted t o radioactive glycine by control brain, but not by glycine encephalopathy brain. This finding. together ~r i t h the results o f recombination experiments between solubilized human brain enzymes and purified protein components o f the bacterial glycine cleavage 5ystem of .Arrhrohacrc,r glnh@orrni\. indicates that the enzyme defect i n glycine encephalopath? involves at least the second or H protein o f the 4-protein glycine cleavage enzyme sy\tem.
Speculation
The severe neurologic syndrome that characterizes glycine encephalopathy, i n contrast to some other forms o f hyperplycinemia, is probably caused by absence o f glycine cleavage enzyme activity and marked elevation o f glycine content i n infantile brain. Since symptoms o f this inherited disorder only appear shortly after birth, a firmly bound endogenous inhibitor o f the glycine cleavage enzyme may accumulate i n brain o f affected infants, who have been protected during fetal life by clearance of the putative inhibitor across the placenta.
I'l;r\rn;r gl!cinc conccrltr:rtions ;rrc. ;rl~norrn;rll! high in ;I \.;rric.ty of cliffcrcnt gcnctic;rIl!~ clctc.~-mined mct;il>olic disorder\ ot i r i t ; r i l t \ ancl children. These di\or'dcrs arc gcncr-ally cla\\ificd ;la k~,totic h!pcr-gl!~c~ncnii:r\ if kcto;rciclo\i\ i\ prc\cnt. ;111cl it a n unusu;rl orgiirlic ;rcicl ;~ccirrn~rl;rtc~\ in l>lootl ;rncl ti\slrc\ and i\ c\c.~-c~tcel In the urine. For c\;rmplc. h!pcr-glycincnli;~ often ;rccomp;rnic\ propionic ;rcicIcmr;r ( 2 ) ;~n d methylm;rlonic acitlernia ( 12). ~rncl it ;II\o h:r\ hccn c~l~\cr-\.ccI in \omc patient\ nith i\ovalc,ric irciclcnli;~ ( I ) anti fi-kctotliiol;~\c dcficicncy ( 7 ) . \Vlicn I\cto;rcido\i\ i\ ;rl1scnt ;~r l t l 110 unusu;rl or-ganic ;~c i d \ can IK dctcctccl in I~ltrocl or urine. hypcrglyc~inc~11ii~r\ ;ire termed nonkctotic. Ho\\cvcr ii~top\y fro111 f o~~r cont~-oI infants. T\ro o f t h e w infant\ cliecl \+ithout evidence of an! mctaholic elisorder. C'ontrol infant .1 had ;I hyperglycinen~~a of undetermined type. h i~t \ho\\ed no neurologic \ymptom\ ( 2 0 ) . C'ontrol infant 4 clied ;~t the age of 2 month\ with hyperglyciricmi;^ \ccondary to mcthylrn;~Ionic ;~c.itlcrni:t. 'The I:~tter cli;~gno\i\ \vas confirmed hy ?;I\ chromatographic d c n l o n \ t r ;~t~o n 01 mcthylmalonic ;lcid in the infant3\ urine. and by ah\cncc of methylrni~lonyl mutasc apocrlzymc i~ctivity in ;I hpccimen ot the intant.4 livcr obt:tincd 2 hr after dcarh ( 2 I ).
Brain and liver \pcei~nen\ \\ere ollt:~inecl ;kt autop\y Irom tllc five glycine cnccphalop:ttI~y patient\ ancl the four control infant\ ( 2 2 ) \\ithin 1-0 hr xftcr death. and \\ere kept fro/cn at X O " until amino acid analy\c\ ancl enzyme assay\ \\ere performed.
MATt'K1AI.S AND Ml1THOllS
Frozen hr;~in spccirnens were homogenized and dcproteinized \vith 0 . 1 M pcrchloric acid as previously descrit>cd ( 1 7 . 18 ). and ;~n~i n o acids anel related compounds were cluantit:itcd o n a Technicon amino acid an;~lyi.er ( 3 1 ) . using the single column lithium citrate huffer elution syhtcrn of Perry cr 111. ( 1 0 ) .
Sl'ANI)AKI) GI.Y('INE CI.FAVA(il: ENZYME ASSAYS
Activity of the glycine clcav;~ge enzyme system was determined irr ~vitro by measuring the rate of formation of 14C0, from (I-14CIglycine. using ;I modification of the method of Bruin clrol. Incubations \\ere routinely carried out for 3 0 min at 37". since preliminary experiments nith homogcnates of human hrain and liver had sho\vn that release of "('0, \\;IS linc~rr \\ith time for at Ici~st 3 0 rnin. The "('0, rcle~rsed tvirs tr~rppcd in NCS Soluhilizcr and counted for radioi~ctivity in :I Packard Tri-C'arh liquid \cintilli~tion counter ( 2 3 ) . Blank reaction mixture\ cont:~inecl all components except the tissue homogcnate. which \$.ab; rcplaced hy 0 . 3 2 M sucro\e. All assays u c r c c;~rried out in duplicate o r triplicate. and results \\ere corrected for any r;tdioactivity ohserved in the blanks. llomogenate\ of Ilrain from control suhiccts and from glycine cncephalopathy patients were mixed in eclual proportions in efforts to demonstrate the presence of a po4\ihle i~lhillitor of the glycinc cleavage enzyme system in the paticnth' hrains. Mixing \\.:IS done immediately hefore enzyme assay in some experiments. whereas in otherz, the mixed hornogcn:~tcs \\ere stirred at z0 for 24 o r 4 8 hr hefore being assayed.
Brain t i s u e hornogenizecl in I 0 volumes ice-cold 0.32 M \ucrosc, conttiining 0.5 mM dithiothrcitol. was di;ily7ed ;it 3" for 7 4 o r 1 6 hr against I 0 0 volunics 0 . 3 2 M sucrose containing 0.5 mM dithiothrcitol in efforts to remove ;I putative enzyme inhihitor. T h e dinlysate was changed at 12-hr intervals. In these experimcnta. undi;~lyzcd i~liquots of the same brain hornogenates. which had stood at 3' during the same intervals. \\ere used to control for deterioration of enzyme activity with time.
l'hc conversion of radioactive bic:~rbonatc to rildioactive glycinc by tlrain hornogenatcs was assayed hy i1 modification of the method of Motokabsa and Kikuchi ( 1 3 ) . Kc;iction mixtures (final volume of 2.6 ml) contained 125 pmol Tri\-l{CI huffer ( p H 8.0). 0.5 p m o l pyridoxill phosphate. I 0 p m o l dithiothrcitol. 5 p n~o l glycinc, 10 pmol sodium bicarhonatc containing 10 pC'i of NaH1'('O,, ( 2 1 ) . and hrain honiogcnatc equiv:ilcnt to I ? nig protein. The mixtures \\ere incubated at 37* for 3 0 min. and the reaction\ were stopped and the niixtures dcproteinizcd hy addition of perchloric acid to give a final concentration of 0 . 4 M . After "CO, had Ilccn released from the acidified mixtures, the dcni~tured protein \\a\ separated hy centrifugation. and the exec.;\ perchlorate was rernovcd hy addition of potas\ium hydroxide ( 1 7 ) .
L:iich reaction supernatant \\as thcn subjected to preparative chrom;rtography on the amino acid ;~nalyzer ( 10) . with collection of the zones of column effluent in nhich serine and glvcine \rere eluted. .l'hese t\\o effluent zones \\ere thcn dricd in : I vacuum dc\iccator. di\solvcd in a small volume of \vater and A c~u ;~\ o l , and their r;ldio;~clivity counted in a scintillation counter. 
PREPARA'I'ION O F BAC'I'EKI,\L < i l . Y C I N t Cl.EAV,Z(it ENZYME FRAC-TI( INS
'l'hc I'.-l'.l.-protein ;ind [I-protein fr;~ctions of ;I llacterial glycirlc cleavage coniplc\ \\ere prcpi1rc.d from . 4 . glol~i/i)rttri.\. \train 13.iO (3.i). i~\ i n g the methoel\ tlescrihccl by Kochi and Kikuchi ( 8 ) . .l'hc\c nlethocls employ ammonium \ultatc precipitation of protein4 from a cruclc bacterial extract. follo\\ed lly ;I \cp;ir;~tion of the protein\ o n a I)Lli\ 1'-cellulo\c column \\ashcd nith 0 . 0 2 hl potas\~um plio\phatc Ilufter ( p H 7.1 ) containing increasing concentration\ of Ni1C.I. Proteins eluted \rith huffcr containing 0 . 2 hl NaC'l \\ere clc\ignatccl P.J. 1.-protein. and protein elutccl \\ ith Ili~ffer containing 0.5 M Nac'l \\a\ clc\ign;~ted I l-protein ( 8 ) .
1:rl/yrnc aswy4 \\ere c;~rriccl out \\ith cornl>inatio~i\ of the \olul~ilii.eel glycinc clcav;~gc~ 'o~nl~lc>\ from I~L J I~~; I I I Ilr;~in ( I .O ml) ;~ncl lxicterial cn/ymc protein fraction\ ( 0 . 5 ml). l ' h c condition\ for thehe rccoml~ination ;i\\ay\ \\ere the \ame a\ clcscrit-recl previously for the \tanelat-d glycinc clea\;~gc a\\ay on I l r a~n and libcr homogcn:itcs. cuccpt t h~t incullations \\crc for 3 0 rnin at 33.5". rnicl\\;~y I~c t \ \ e c n the t c r n l~c r ;~t~~r -c \ optimal for the 1-r;lc.t~-rial glycinc clca\,agc \!\tern (30") and the human \?stem ( 3 7 " ) .
Urine ancl pla\rna specimens from the glyci~rc cnccpli;~Iopathy patient4 \\ere ;~ciclificcl to 1711 1.0 ancl c,\tr-acted into ethyl iicctatc. .I'he cstractcd organic acid4 \\ere methyl c\tcr-ificd and m:~lonic ;icidcmia. h;ld higher gI!cinc cleavage ;~ctivit! in hi\ suhicctcd to gas chrorn;itography in ;I \car-ch for or-ganic acids Ilrain th;in clid either-ot the other-control inf;int\. o r sc\cr-al k n o \ \ n to llc a\soci;itccl \\it11 hypcrgl!cincri~i;~s ( 6 ) . 2 7 T h e i1uantitic\ of glyccric acid contained in the original urine and hr;iin specimen\ heforc cxtl-action \ \ e r e then cstim~itcd from the mcasurcd ratio\ of the intenhitic\ of ttl/c, 180-103. ;ind the re1;itivc incrc;i\c\ produced in t h e w r;itios when k n o n n amounts of ~I y c c r i c ;icicI \vcrc added to \ample\ heforc extraction.
.l'he contcnt of plycine \ \ a \ markcclly c1cv;itccl (2-to 8-folll) in all cx;irnincd region\ of autopsied hrairl from the gl!cine cnceph;ilop:ithy patient\. :I\ cornparcil to the \Lime region\ of brain from four control infant\ (Table 1 ) . I t i\ particularly notc\\orthy that glycinc contcnt \\;IS normal in the hr-ain of control infant 4 who dicd \\itti hypcrglycinemi;~ \ccondary to methylmaIonic i~cidcmia. 'I'hc glycinc content of hrain r i \ c stc:tdily for 24-48 hr after death. l;irgeIy hecausc of the hydrolysis of p1ut;ithione. Thus the glycine \aluc\ \ho\\n in 'fat3lc 1 ;ire probably somc\vh;it higher than they \\ere during life. o r \vcrc stir-re11 together ;it 2" for 24-48 hr hcforc ;i\\;iys. n o convincing c\idcncc coulil he found for inhihition ol the cx)ntrol inf;~nt'\ glycinc c~l c a \ ;~g c c n y m c sy\tcm. T h e ;Imoitnts ot ",('O, for-mc~l Ily \11ch ~l i i x t u l .~\ \ \ e r e ~~s u ;~l l y similar to tho\c formed Ily tlic same ; m o u n t s of contr-01 Ilr~iin 1iomogcn;itc assayed lone. Table 3 shows the results of a typical dialysis experiment.
When honiogcnatc of brain from a control infant was assayed immediately after homogenization. and again after 24 a n d 46 hr o f dialysis. glycine cleavage enzyme activity increased appreciably. That this heightened enzymc activity was not d u e t o contamination by Mycoplasn~a o r other microorganisms was shown by the failure of enzyme iictivity to increase in homogenates stirred in the same cold room for the s a m e periods. W e 'fahlc 2 . (;/yc.it~c, c~lctrt~rc~c~ c3tr,-yttlc, rrc.~it,i!\. itr hrrrltl ttrrtl li1,c,r1 ;~cidemia ( 0 ) . the urines of patients I a n d .l, a n d the hrains of patients .?, 4 , and -5 \vcrc also carefully esamined for glyccric acid by combined gas cliromatograpl~y-n~irss spectrornctr> . l'ithle 4 .;ho\vs the itmounts of glyceric ~rcid found in thc\e urinc ancl hrain specimens. T h e concentration?, of glyccric acid i l l the urincs of patients I a n d . ? \\ere ithout 3 orclers of magnituclc lower than K~l v r a a (,r (11. ( 4 ) foul;d in the urine of their ~xrticnt with 11-glyccric aciderni:~. Very small amounts of glyceric acid \ \ e r e present in the hrains of glycine cnccphalop:rtl1y patient\ .?. 4 . itncl 5 , hut a comp;rr;rble amount \\as also present in the hrain of control infant 4 . w h o hire1 ~liethyl~ll;rlo~lic ; I C~C~C I I I~; I . l ' h e glyc,ine cleavirgc en/ymc \\stern in human I)rain is prohitbly similar to that \vliich has heen isolated from rat liver rnitochonclria hy M o t o l i a~a and Kikuchi ( 13-1 5 ) . a n d from A . no radioactive glycine at all \va\ formed % h e n hrain homogcn:ttc from a !lycinc enccphalopathy patient was similarly inculxrtcd.
No r:tcl~o;~ctive scrinc was formecl in either experiment. Failure to produce radioactive glycine f r o m radioirctivc bic:rrbon;rtc indicates that the enzyme deficiency in glycinc cncephalopatliy must involve o n e o r both of the first t\\o proteins in the system. 1'-pl-otein isolirted from A . ~1ol1ifi1rttri.s is capithlc o f p:rrticipirting in glycine cleavage with the other thl-ec components i\olatccl from rat livcr mitochondri;~ ( X ) . With the proccclurc \\c. u\ecl ( 8 ) . I,actcr~itl f'-protein is ohtained cornhined \\it11 'I-a n d I--pr-olein. ~h c r c i r s Ixictcrial 11-protein i h obtained a s a sepitrittc fraction. 13iteteri:rl and m:tmnlalinn H-protein is heat stable. \\hereits 1'-. .I'-. irnd L-proteins a r e I-~rpidly inactivated hq hcirting. Tahle 5 shows the cleavage of glycine to C'O, mhich occurred \\hen bacterial 1',7'.1_ and ki fractions were cornhined \vith t h e soluhilizcd brain cnyyrnc system ohtaincd from a control suhjcct's hrain. ancl from a glycine enccpholop;rth\. ' Rc\ult\ arc tlic mc,;ln\ of t\\o ;i\\a!\. corrc~ctcd for an) racl~o;ictiv~t! ohscrvcd 111 the cn/ynic hliit~h\, iincl ;ire cx~)re\\ccI ;I\ cou~lt\ per 111111 tornicd for 30-~nin ~ncul~;it~on tit 33.5" ' tic:ited 111 a h o~l~n g water I~ath Ior 3 ~nin to dc\tro! all cn/!mc, protein\ e\ccpt 11-l~rolc~ri ' S~~I~it~ili/;itio~i of the 11r:i111 c~l/)riic~ co~i~plcx rc\ult\ 111 r:ipicl l o \ \ 01
['-protein acti\ it) .. formed from glycine when bacterial P..I'.L fraction was combined with glycine encephalopathy brain. This suggested that H-protein was absent or inactive in the solubilized enzyme system from the glycine enccphalopathy patient's hrain.
The failure to form ' T O , when glycinc cncephalopathy brain and bacterial H-protein u c r c combined does not necessarily mean that P-protein was abnorn~al in this brain. "CO, u a s also not formed when the solubilized enryme system from control brain and bacterial H-protein were combined. Unlikc the isolated bacterial P-protein, which is relatively stable. partially purified mammalian P-protein has been found to be very unstahle. I t loses iOc4 of its initial activity even when stored at 2 ( P for as little ah 24 hr (14). We did not attempt to fractionate components of the enzyme systcni from brain. However. even the solubilization of the enzyme system which was required in order to carry out recombination experiments with the birctcrial fractions resulted in rapid loss of P-protein activit). Thus. \ve were unable to prove whether or not P-protein activity was normal in intact brain of glycine enccphalopathy patients.
DISCUSSION
Glycinc cnccphalopathy differs from the lietotic hyperglycincmias. and from other forms of so-called nonlietotic hypcrglycincmia. in a marked elevation of the glycine content of the brain. which is in turn reflected in an abnorn~ally high concentration of glycine in the CSF. This is illustrated by the high brain glycine levels in our five patients. as well as by the elevated brain glycine values found in a single patient by Bachrnann c. 1 (11. (3) . On the other hand. brain glycinc values at autopsy were normal in a single patient with hypcrglycinemiir secondary to propionic acidcmia ( 2 ) . and in our hyperglycinemic infants \\ith methylmaIonic acidcmia and with an undetermined type of hyperglycinemia (Table I ) .
It is possible that the high levels of glycinc in brain in glycirle encephalopathy are directly responsible for the severe ncurologic symptoms characteristic of this disorder. Glycine probably functions as an inhibitory neurotransmitter in the spinal cord. and possibly at certain synapses in the brain as well (10) . and o great excess of such a transmitter might well disrupt brain activity. A deficiency of N\N1"-niethylcnetetr;~hydrof~>I:rt~ ( Fig.  I , rc;ictic)n 3 ) 4 c c r n h rnuch l e~ likely 10 I>c the ncul-otosic f;~cror in glycine encephalopathy, since other pathway\ le:rd to the formation of thih folate intermediate.
Comparison of it1 17irro glycine cleavage enryme activity in brain and liver homogenates of glycine cncephalopathy patients shows a complete absence of activity in brain. \vhercas enzyme activity in liver is reduced. but still readily measured (Table 2 ) . This difference between brain and liver is unexplained. It could be accounted for if a necessary activator of the glycine cleavage system failed to penetrate into brain. but was present in reduced amounts in livcr. o r if a rel;rtivcly lipid-soluble inhihitor of the enzyme system accumulated in greater amounts in brain than in liver.
Failure of the carboxyl group of glycine to exchange with NaH1'CO:, in homogenates of glycine cnccphalopathy brain it1 tirro den~onstrates that an enzyme deficiency must exist within the first two steps of the glycine cleavage sy\tem (Fig. I ) . although it tells us nothing about the integrity of the third and fourth steps. The recombination experiments using active Pprotein derived from A . g 
l o h i f i~r t~~i v
(in the I'..I'.L fraction). and H-protein derived from human brain suggest thirt H-protein --is inactive in glycine cncep1i;rlopathy. H-protein derived from rat liver mitochondri:~. and presumably the H-protein in human hrain, is a small protein with ;I m o l c c u l ;~~ weight of ;rb(tut 17.000. uhich is heat stable and contains a functional disulfidc gl-oup in its molecule ( 1 3-15) . I t \ function i\ t o accept the -CH,NH, fragment derived from glycine. a n d to tr;insfer it\ one carbon unit to tetrahydrofolate (Fig. 1 ) .
Lllcvatcd glycinc levels in brain appear highly toxic. ;rlthough elevated glycinc concentrations in plasnra seem to be harmless.
I his is borne out by our earlier finding (20) that at least one child \\it11 marked hypcrglycinenlia enjoyed re:rsonablc health and was entirely free from neurologic symptoms. where;~s an infant \vhc) eventually died from plycine enccphalopathy repeatedly had normal glycine concentrations in her fasting plasma. A striking feature of glycine encephalopathy is its onset shortly aftcr birth. often on the second or third day of lifc ( I 6 This \uggests that the absence of glycine clc;rvage enzyme activity in the brain and the reduced enzyme activity in the liver. apparently caused by failure of the H-protein. arc not due to : I structural abnormality of the apocnzyme. If this were the case, glycinc in plasma might cross the placenta intc> the niuternal circulation during fctal lifc. but glycine should accumulate in the fetal brain and cause brain d:rmage long before birth. It does not seem reasonable to postulate that glycine could he transported freely out of fetal brain up to the t i~n e of I>irth. and then suddenly fail to cross from brain into the circul;rtion after birth. We believe that the best explanation for the sudden onset of glycinc enccphalopathy early in infancy is cithcr lack of an enzyme activator which might be supplied by the mother during fetal life, o r presence of an enzyme inhibitor which is disposed of across the placenta during fetal life. Another possibility is that production of the hypothetical inhibitor commences only at birth in all infants, but the patients with glycinc encephalopathy fail to nietaboli~c it further.
T h e mixing and dialysis experiments that we carried out on brain homogenates have provided n o evidence for the presence in the brain o f glycinc cncephalopathy patients of a loosely bound inhibitor of the glycine cleavage enzyme system. Ho\v-ever. they have not excluded the possible presence of an inhibitor which is so firmly bound to protein that activity cannot be restored in homogcn;rtes of the patients' brains. Addition of brain homogenate containing such a firmly bound inhibitor to a hornogenate of normal brain might also not result in inhibition of the active enzyme systcni in the 1:rtter. Daly (' 1 ol. ( 5 ) have rccently prcscritc~l cvidcncc for the existence of one or Inore nondialyzable endogenous inhibitors of the glycine cleavage enzyme system in rat brain. so that it is reasonable to envisage the occurrence of such conlpounds in human brain. I t is clear. however. that in our patients glyceric acid was not the putative inhibitor.
Future studies of glycinc cncephalopathy should perhaps focus on a search for such an endogenous enzyme inhibitor. This hypothcticirl inhibitor might readily be degraded in normal individuals. but not in affected infants. The latter might be protected by the placental circulation during fetal lifc. only to have the inhibitor accumulate in liver and especially in brain after birth.
Glycinc content was measured in autopsied brain from five infants dying with plycine encephalopathy and four control infants. including two with other types of hyperglycinemin. Activity of the glycine cleavage enzyme system was determined in autopsied brain and liver from these nine inf;rnts. Glycine content was elevated 2-to 8-fold in the brains of the glycine cncephalopathy patients. Glycine cleavage enzyme activity was undetectable in their brains. but present at reduced levels in their livers. Dialysis and mixing experinients failed either to demonstrate o r to disprove the presence of an endogenous inhibitor of the glycine cleavage cnzyme system in the brains of the glycinc enccphalopathy patients. However. D-glyceric acid was excluded as a possible inhibitor. Failurc of brain homogcnates from glycinc encephalopathy patients to convert radioactivc hicarbon:rtc into radioactive glycinc it1 ~V r r o , as well ;IS tllc results of rcco~nhin:~tio~i experiments with soluhilized hitm:rn brain cnlyrncs ancl purified protcin components ot a Ix~ctcri;il glycinc cleavage systcnl. showcd that the cnzyme defect in glycinc enccph:~lopatl~y must involve at least the ti-protein 01' the -I-protein glycinc cleavage en;ryrnc \ystenl.
